keyword
https://read.qxmd.com/read/38614649/assessment-and-management-of-chronic-kidney-disease-in-people-living-with-obesity
#21
JOURNAL ARTICLE
Peter Jacob, Kieran McCafferty
Obesity and chronic kidney disease (CKD) are common and frequently coexisting medical conditions. Already well known to be a risk factor for type 2 diabetes mellitus (T2DM), ischaemic heart disease, stroke, hypertension, malignancy and premature death, obesity also predisposes to CKD. Elevated weight leads to declining renal function through several mechanisms, including established pathways via metabolic syndrome, hypertension and T2DM, but also through relatively recently understood glomerulosclerosis, directly related to obesity...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38610904/acute-appendicitis-in-the-elderly-a-nationwide-retrospective-analysis
#22
JOURNAL ARTICLE
Malkiely Gal, Paran Maya, Kobo Ofer, Khan Mansoor, Abbou Benyamine, Kessel Boris
Background: Acute appendicitis (AA) in older individuals remains understudied. We aimed to assess AA characteristics in patients older than 60 years and evaluate the impact of comorbidities. Methods: This retrospective study analyzed data from the American National Inpatient Sample between 2016 and 2019 to compare AA characteristics in patients younger and older than 60 years. Results: Of the 538,400 patients included, 27.5% were older than 60 years. Younger patients had a higher appendectomy rate ( p < 0...
April 8, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608516/sars-cov-2-infection-increases-long-term-multiple-sclerosis-disease-activity-and-all-cause-mortality-in-an-underserved-inner-city-population
#23
JOURNAL ARTICLE
Roham Hadidchi, Stephen H Wang, David Rezko, Sonya Henry, Patricia K Coyle, Tim Q Duong
BACKGROUND: Although certain subsets patients with multiple sclerosis (MS), an immune-mediated disorder, are at higher risk of worse acute COVID-19 outcomes compared to the general population, it is not clear whether SARS-CoV-2 infection impacts long-term outcomes compared with MS patients without COVID-19 infection. OBJECTIVES: This study investigated MS disease activity and mortality 3.5 years post SARS-CoV-2 infection and compared with MS patients without COVID-19...
April 8, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38606848/evaluating-prescription-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-ii-receptor-blockers-in-patients-with-diabetes-and-albuminuria
#24
JOURNAL ARTICLE
Kittiphan Chienwichai, Phirada Chaloemwa, Sorawat Sangkaew, Arunchai Chang
AIM: Although guidelines recommend the use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II receptor blockers (ARB) in patients with diabetes, hypertension, and albuminuria, their use remains suboptimal in several developed countries. Limited data are available on ACEi/ARB use in developing countries. Here, we assessed the use of ACEi/ARB and identified factors contributing to their underutilization at Hatyai Hospital, Thailand. MATERIALS AND METHODS: This retrospective cross-sectional study was conducted using data from the Hatyai Hospital database...
April 12, 2024: Clinical Nephrology
https://read.qxmd.com/read/38606791/molecular-and-pathophysiological-relationship-between-obesity-and-chronic-inflammation-in-the-manifestation-of-metabolic-dysfunctions-and-their-inflammation%C3%A2-mediating-treatment-options-review
#25
REVIEW
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis-Nobelos
Obesity reaches up to epidemic proportions globally and increases the risk for a wide spectrum of co‑morbidities, including type‑2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular diseases, non‑alcoholic fatty liver disease, kidney diseases, respiratory disorders, sleep apnea, musculoskeletal disorders and osteoarthritis, subfertility, psychosocial problems and certain types of cancers. The underlying inflammatory mechanisms interconnecting obesity with metabolic dysfunction are not completely understood...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38606379/relevance-of-obesity-related-organ-damage-and-metabolic-syndrome-classification-in-cardiovascular-and-renal-risk-stratification-in-patients-with-essential-hypertension
#26
JOURNAL ARTICLE
Luigi Petramala, Antonietta Gigante, Francesca Sarlo, Adriana Servello, Francesco Circosta, Luca Marino, Antonello Ciccarelli, Giuseppe Cavallaro, Claudio Letizia
INTRODUCTION: Hypertension is a relevant cardiovascular comorbidity. Adipose tissue represents a metabolically active tissue involved in the regulation of blood pressure and metabolic alterations. In recent decades, several classifications for the metabolic syndrome (MS) have been proposed. Recently, a new syndrome called the "Cardiovascular-kidney-metabolic" (CKM) syndrome was identified, to determine patients at high cardiovascular and metabolic risk. The aim of the study was to compare different classifications in a large population of hypertensive patients...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38605798/apri-as-a-predictor-of-severe-dengue-fever
#27
JOURNAL ARTICLE
Ajith K Jayachandran, Vincy Nelson, K Anisha
INTRODUCTION: The AST/platelet ratio index (APRI) is a well-researched indicator of liver fibrosis. Some studies have shown that APRI can be used as a predictor of severe dengue, but the data is limited. As dengue epidemics are common in our country with limited healthcare resources, we believe APRI can help emergency physicians/primary physicians in predicting the severity of dengue and plan for the appropriate use of limited healthcare resources. OBJECTIVE: 1) To determine the utility of APRI as a predictor of severe dengue...
February 2024: Journal of Family Medicine and Primary Care
https://read.qxmd.com/read/38604628/cohort-profile-the-persian-dena-cohort-study-pdcs-of-non-communicable-diseases-in-southwest-iran
#28
JOURNAL ARTICLE
Javad Harooni, Farahnaz Joukar, Reza Goujani, Masoumeh Khalighi Sikaroudi, Alireza Hatami, Mohammad-Amin Zolghadrpour, Mahdi Hejazi, Zahra Karimi, Fatemeh Rahmanpour, Sakineh Askari Shahid, Mohammad-Reza Jowshan
PURPOSE: This study conducted in Dena County is a population-based cohort study as part of the Prospective Epidemiological Research Studies in Iran (PERSIAN). The specific objectives of this study were to estimate the prevalence of region-specific modifiable risk factors and their associations with the incidence of major non-communicable diseases (NCDs). PARTICIPANTS: This PERSIAN Dena Cohort Study (PDCS) was conducted on 1561 men and 2069 women aged 35-70 years from October 2016 in Dena County, Kohgiluyeh and Boyer-Ahmad Province, Southwest Iran...
April 10, 2024: BMJ Open
https://read.qxmd.com/read/38600564/frail-hypertensive-older-adults-with-prediabetes-and-chronic-kidney-disease-insights-on-organ-damage-and-cognitive-performance-preliminary-results-from-the-caryatid-study
#29
JOURNAL ARTICLE
Gaetano Santulli, Valeria Visco, Michele Ciccarelli, Mario Nicola Vittorio Ferrante, Piero De Masi, Antonella Pansini, Nicola Virtuoso, Armando Pirone, Germano Guerra, Veronica Verri, Gaetano Macina, Alessandro Taurino, Klara Komici, Pasquale Mone
BACKGROUND: Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often accompanied by cardiovascular comorbidities such as hypertension, elevating the risk of pre-frailty and frailty. Albuminuria is a hallmark of organ damage in hypertension amplifying the risk of pre-frailty, frailty, and cognitive decline in older adults. We explored the association between albuminuria and cognitive impairment in frail older adults with prediabetes and CKD, assessing cognitive levels based on estimated glomerular filtration rate (eGFR)...
April 10, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38598574/pragmatic-trial-of-hospitalization-rate-in-chronic-kidney-disease
#30
RANDOMIZED CONTROLLED TRIAL
Miguel A Vazquez, George Oliver, Ruben Amarasingham, Venkatraghavan Sundaram, Kevin Chan, Chul Ahn, Song Zhang, Perry Bickel, Samir M Parikh, Barbara Wells, R Tyler Miller, Susan Hedayati, Jeffrey Hastings, Adeola Jaiyeola, Tuan-Minh Nguyen, Brett Moran, Noel Santini, Blake Barker, Ferdinand Velasco, Lynn Myers, Thomas P Meehan, Chester Fox, Robert D Toto
BACKGROUND: Despite the availability of effective therapies for patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large-scale trials examining the implementation of guideline-directed therapy to reduce the risk of death and complications in this population are lacking. METHODS: In this open-label, cluster-randomized trial, we assigned 11,182 patients with the kidney-dysfunction triad who were being treated at 141 primary care clinics either to receive an intervention that used a personalized algorithm (based on the patient's electronic health record [EHR]) to identify patients and practice facilitators to assist providers in delivering guideline-based interventions or to receive usual care...
April 4, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38597552/testosterone-deficiency-in-hypertensive-men-prevalence-and-associated-factors
#31
JOURNAL ARTICLE
Leandra Analia Freitas Negretto, Nelson Rassi, Leonardo Ribeiro Soares, Amanda Bueno Carvalho Saraiva, Maria Emília Figueiredo Teixeira, Luciana da Ressurreição Santos, Ana Luiza Lima Souza, Paulo Cesar B Veiga Jardim, Weimar Kunz Sebba Barroso de Souza, Thiago de Souza Veiga Jardim
BACKGROUND: Testosterone deficiency (TD) is a prevalent condition in our midst and still very neglected. Arterial hypertension (AH) is one of the possible associated factors. OBJECTIVES: To determine the prevalence of TD in a hypertensive male population and the factors associated with its occurrence, such as age, time since hypertension diagnosis, number of antihypertensive classes, body mass index (BMI), diabetes, dyslipidemia, chronic kidney disease (CKD), positive symptoms of TD (positive ADAM questionnaire) and use of spironolactone...
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38596604/accelerated-atherosclerosis-in-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-case-report
#32
Natalia Andrea Uribe Ruíz, María Paulina Villa, Alberto Álzate Gutiérrez, Clara Inés Saldarriaga Giraldo, José Gregorio Thorrens Ríos
Accelerated atherosclerosis has been identified as a complication of multiple autoimmune diseases, among which Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis stands out. We describe the case of a 60-year-old patient with a history of hypertension, diabetes mellitus, and chronic kidney disease of unknown etiology, who presented two acute coronary syndromes with only a six-month difference. Rapid progression of coronary involvement was evidenced, along with increased markers of inflammatory response, usual interstitial pneumonia on tomography, and positive anti-myeloperoxidase antibodies (anti-MPO), leading to the diagnosis of microscopic polyangiitis (MPA)...
2024: Arch Peru Cardiol Cir Cardiovasc
https://read.qxmd.com/read/38595876/the-prevalence-of-nephrolithiasis-and-associated-risk-factors-among-the-population-of-the-riyadh-province-saudi-arabia
#33
JOURNAL ARTICLE
Abdullah M Alshubaili, Abdulaziz F Alotaibi, Khalid A Alsaleh, Abdulaziz I Almogarri, Abdullah A Alanizi, Saif S Alsaif, Ahmad S Alghamdi, Nasser M Alnazari, Amwaj Almalki
Background and objective Kidney stones, also referred to as nephrolithiasis or renal calculi, is a condition where crystal depositions are formed within the kidney and ideally excreted from the body via the urethra with no pain; however, larger calculi may cause significant pain and require further medical assistance. The vast majority of patients who develop renal calculi form calcium stones, which are either a composition of calcium oxalate or calcium phosphate. Other types include uric acid, struvite, and cysteine...
March 2024: Curēus
https://read.qxmd.com/read/38593202/the-role-of-exercise-training-on-cardiovascular-risk-factors-and-heart-disease-in-patients-with-chronic-kidney-disease-g3-g5-and-g5d-a-clinical-consensus-statement-of-the-european-association-of-preventive-cardiology-eapc-of-the-esc-and-the-european-association
#34
JOURNAL ARTICLE
Evangelia Kouidi, Henner Hanssen, Kirsten Anding-Rost, Adamasco Cupisti, Asterios Deligiannis, Clemens Grupp, Pelagia Koufaki, Paul Leeson, Eva Segura-Orti, Amaryllis Van Craenenbroeck, Emeline Van Craenenbroeck, Naomi Clyne, Halle Martin
Cardiovascular (CV) morbidity and mortality is high in patients with chronic kidney disease (CKD). Most patients reveal a high prevalence of CV risk factors such as diabetes or arterial hypertension and many have manifest cardiovascular disease (CVD), such as coronary artery disease and chronic heart failure with an increased risk of clinical events including sudden cardiac death. Diabetes mellitus and hypertension contribute to the development of CKD and the prevalence of CKD is in the range of 20%-65% in diabetic and 30%-50% in hypertensive patients...
April 9, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38592226/cognitive-impairment-and-brain-atrophy-in-patients-with-chronic-kidney-disease
#35
REVIEW
Kazuhiko Tsuruya, Hisako Yoshida
In Japan, the aging of the population is rapidly accelerating, with an increase in patients with chronic kidney disease (CKD) and those undergoing dialysis. As a result, the number of individuals with cognitive impairment (CI) is rising, and addressing this issue has become an urgent problem. A notable feature of dementia in CKD patients is the high frequency of vascular dementia, making its prevention through the management of classical risk factors such as hypertension, diabetes mellitus, dyslipidemia, smoking, etc...
February 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590611/the-prevalence-of-cardiovascular-diseases-chronic-kidney-disease-and-obesity-in-patients-with-type-2-diabetes-mellitus-and-the-description-of-concurrent-treatments-a-two-center-retrospective-cross-sectional-study-in-saudi-arabia
#36
JOURNAL ARTICLE
Omar A Alshaya, Ghazwa B Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S Alyami, Omar A Almohammed
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), and obesity are associated with increased morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Nonetheless, their prevalence among patients with T2DM in Saudi Arabia (SA) remains unknown. As current guidelines recommend, these comorbidities require adding certain antidiabetic agents with cardiorenal benefits. However, the prescribers' adherence to these recommendations remains unclear...
May 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38590481/the-role-of-telemedicine-in-enhancing-chronic-kidney-disease-ckd-management-and-dialysis-care
#37
EDITORIAL
Ramchandani Santosh, Yaqub Nadeem Mohammed, Zubair Rahaman, Sakshi Khurana
Telemedicine has emerged as a transformative solution in the realm of healthcare, particularly in addressing the complexities and challenges associated with chronic kidney disease (CKD) and dialysis care. This editorial explores the potential of telemedicine in revolutionizing the management and treatment of kidney diseases, highlighting its role in mitigating the burdens faced by healthcare systems worldwide. With the advent of high-quality audio and visual platforms, telemedicine has facilitated remote healthcare delivery, enabling healthcare professionals to provide exceptional care from a distance...
March 2024: Curēus
https://read.qxmd.com/read/38587764/the-etiology-of-advanced-chronic-kidney-disease-in-southeast-asia-a-meta-analysis
#38
JOURNAL ARTICLE
Ni Made Hustrini, Endang Susalit, Felix Firyanto Widjaja, Anandhara Indriani Khumaedi, Olaf M Dekkers, Merel van Diepen, Joris I Rotmans
INTRODUCTION: Chronic kidney disease (CKD) etiology varies greatly between developed and developing countries. In addition, differences in underlying pathogenesis and therapeutic options affect the progression towards advanced-CKD. This meta-analysis aims to identify the etiology of advanced-CKD in Southeast Asia. METHODS: A systematic search in four electronic-databases and complementary search on national kidney registries and repository libraries was conducted until July 20, 2023...
April 8, 2024: Journal of Epidemiology and Global Health
https://read.qxmd.com/read/38584180/risk-of-diabetic-retinopathy-and-diabetic-macular-oedema-with-sodium-glucose-cotransporter-2-inhibitors-and-glucagon-like-peptide-1-receptor-agonists-in-type-2-diabetes-a-real-world-data-study-from-a-global-federated-database
#39
JOURNAL ARTICLE
Aikaterini Eleftheriadou, David Riley, Sizheng S Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
AIMS/HYPOTHESIS: A protective role of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic retinopathy and diabetic macular oedema has been described in some recent studies, which may extend beyond glycaemic control. We aimed to review the clinical impact of SGLT2i and GLP1-ra therapy on the risk of diabetic retinopathy and diabetic macular oedema in individuals with type 2 diabetes taking insulin. METHODS: This is a retrospective cohort analysis of approximately two million people with type 2 diabetes receiving insulin across 97 healthcare organisations using a global federated health research network (TriNetX, Cambridge, USA)...
April 8, 2024: Diabetologia
https://read.qxmd.com/read/38581843/risk-factors-for-chronic-kidney-disease-in-middle-eastern-patients-with-type-2-diabetes-mellitus-a-cross-sectional-study-using-the-kdigo-classification
#40
JOURNAL ARTICLE
Randa Farah, Abdulrahman Alhajahjeh, Oraib Al-Farahid, Hana Abuzaid, Dana Hyassat, Gaith Al-Khuraisat, Rana Al-Shimi, Faisal Athamnah, Ahmad Aldurgham, Husam Aljabiry, Kamel Ajlouni
AIMS: Chronic kidney disease (CKD) is prevalent in patients with type 2 diabetes mellitus (T2DM). This study aimed to investigate risk factors for CKD progression across the kidney disease-Improving Global Outcomes (KDIGO)categories in a Middle Eastern population beyond hyperglycemia as emphasized by KDIGO guidelines which classifying CKD by cause and severity. METHODS: This cross-sectional study targeted 1603 patients with T2DM. Risk factors for CKD progression were determined using odds ratios (ORs) and 95 % confidence intervals (CIs)...
March 27, 2024: Journal of Diabetes and its Complications
keyword
keyword
32832
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.